Marksans Pharma Ltd (MARK)

NSE


Symbol		Exchange		Currency
MARK	·	NSE	·	INR	Real-time
MARK	·	BSE	·	INR	Delayed

Currency in INR

MARK Pro Research

321.30

+0.45(+0.14%)

Closed·05:59:59

Fair Value

Unlock Value

Day's Range

313.85

327.00

52 wk Range

155.00

345.50

MARK Income Statement

Assess the Marksans Pharma Ltd income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the MARK net worth.

Period Ending:

2017

31/03

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

2025

31/03

2026

31/03

Total Revenues

aa.aa

14,908.39

18,521.39

21,774.07

26,228.45

29,509.38

Total Revenues Growth

aa.aa

+8.33%

+24.23%

+17.56%

+20.46%

+12.51%

Cost Of Revenues

aa.aa

7,295.49

9,400.93

10,740.47

11,981.1

13,378.59

Gross Profit

aa.aa

7,612.9

9,120.46

11,033.6

14,247.35

16,130.79

Gross Profit Growth

aa.aa

-1.21%

+19.8%

+20.98%

+29.13%

+13.22%

Gross Profit Margin %

aa.aa

51.06%

49.24%

50.67%

54.32%

54.66%

Other Operating Expenses, Total

aa.aa

5,471.86

6,243.14

7,190.53

9,754.04

11,104.9

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+18.59%	+14.1%	+15.17%	+35.65%	+13.85%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2,250.46	2,522.86	3,058.84	3,620.25	4,350.08
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2,773.64	3,201.75	3,388.99	5,299.93	5,768.5

Operating Income

aa.aa

2,141.04

2,877.32

3,843.07

4,493.31

5,025.89

Operating Income Growth

aa.aa

-30.76%

+34.39%

+33.56%

+16.92%

+11.85%

EBIT Margin %

aa.aa

14.36%

15.54%

17.65%

17.13%

17.03%

Net Interest Expenses

aa.aa

2.33

59.41

225.84

185.37

35.53

Net Interest Expenses Growth

aa.aa

+108.77%

+2,449.79%

+280.14%

-17.92%

-80.83%

Interest Expense, Total

aa.aa

-57.4

-60.96

-112.03

-116.6

-241.25

Interest And Investment Income

aa.aa

59.73

120.37

337.87

301.97

276.78

Other Non Operating Expenses, Total

aa.aa

330.58

442.44

164.5

331.63

532.67

EBT, Excl. Unusual Items

aa.aa

2,473.95

3,379.17

4,233.41

5,010.31

5,594.09

Gain (Loss) On Sale Of Assets

aa.aa

-2.64

0.94

-0.33

-0.64

Other Unusual Items, Total

aa.aa

1.16

0.39

22.75

-0.17

EBT, Incl. Unusual Items

aa.aa

2,475.11

3,376.53

4,235.26

5,039.67

5,605.55

EBT, Incl. Unusual Items Growth

aa.aa

-18.09%

+36.42%

+25.43%

+18.99%

+11.23%

EBT, Incl. Unusual Items Margin

aa.aa

16.6%

18.23%

19.45%

19.21%

19%

Income Tax Expense

aa.aa

606.97

723.32

1,086.31

1,213.48

1,404.91

Net Income to Company

aa.aa

1,868.14

2,653.21

3,148.95

3,826.19

4,200.64

Minority Interest

aa.aa

9.87

-11.95

-20.44

-21.64

Net Income

aa.aa

1,868.14

2,663.08

3,137

3,805.75

4,179

Net Income Growth

aa.aa

-21.68%

+42.55%

+17.8%

+21.32%

+9.81%

Net Income Margin %

aa.aa

12.53%

14.38%

14.41%

14.51%

14.16%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

1,868.14

2,663.08

3,137

3,805.75

4,179

Basic EPS - Continuing Operations

aa.aa

4.56

6.41

6.92

8.4

9.22

Basic EPS - Continuing Operations Growth

aa.aa

-21.68%

+40.46%

+7.98%

+21.32%

+9.81%

Diluted EPS - Continuing Operations

aa.aa

4.56

6.41

6.92

8.4

9.22

Diluted EPS - Continuing Operations Growth

aa.aa

-21.68%

+40.44%

+7.96%

+21.36%

+9.78%

Basic Weighted Average Shares Outstanding

aa.aa

409.31

415.4

453.16

Diluted Weighted Average Shares Outstanding

aa.aa

409.31

415.4

453.16

Dividend Per Share

aa.aa

0.25

0.5

0.6

0.8

0.9

Dividend Per Share Growth

aa.aa

+100%

+20%

+33.33%

+12.5%

EBITDA

aa.aa

2,404.5

3,203.41

4,337.25

5,053.87

5,645.67

EBITDA Growth

aa.aa

-28.25%

+33.23%

+35.39%

+16.52%

+11.71%

EBITDA Margin %

aa.aa

16.13%

17.3%

19.92%

19.27%

19.13%

EBIT

aa.aa

2,141.04

2,877.32

3,843.07

4,493.31

5,025.89

* In Millions of INR (except for per share items)

FAQ

What was Marksans Pharma Ltd’s revenue at year end?

At the end of the last reported fiscal year, Marksans Pharma Ltd (MARK) recorded total revenue of 29,509.38 million INR.

How much revenue did Marksans Pharma Ltd report in the most recent quarter?

In its most recent quarterly earnings report, Marksans Pharma Ltd posted revenue of 8,407.96 million INR.

What was Marksans Pharma Ltd’s net income for the year?

For the full year, Marksans Pharma Ltd reported net income of 4,179.00 million INR.

How much net income did Marksans Pharma Ltd post in the last quarter?

In the most recent quarter, Marksans Pharma Ltd (MARK) posted net income of 1,571.67 million INR.

What was Marksans Pharma Ltd’s gross profit for the year?

Gross profit for the year was reported at 16,130.79 million INR.

How much gross profit did Marksans Pharma Ltd generate last quarter?

Marksans Pharma Ltd recorded gross profit of 4,973.30 million INR in its latest quarterly report.

What was Marksans Pharma Ltd’s annual operating income?

For the full year, Marksans Pharma Ltd (MARK) reported operating income of 5,025.89 million INR.

What was Marksans Pharma Ltd’s operating income last quarter?

Quarterly operating income was 1,881.71 million INR.

What was Marksans Pharma Ltd’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 2,036.66 million INR.

What was the quarter-over-quarter change in EBITDA for Marksans Pharma Ltd?

EBITDA changed by 8.87% million INR compared to the last quarter.

What is Marksans Pharma Ltd’s most recent gross profit margin?

The latest reported gross profit margin for Marksans Pharma Ltd (MARK) is 59.15% million INR.

What is Marksans Pharma Ltd’s most recent net income margin?

Net income margin based on recent financials is 18.69% million INR.

What is Marksans Pharma Ltd’s most recent EBIT margin?

Marksans Pharma Ltd reported an EBIT margin of 22.38% million INR based on current figures.

How did Marksans Pharma Ltd’s revenue change compared to the previous quarter?

Revenue changed by -1.79% million INR compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Marksans Pharma Ltd?

In the latest quarter, gross profit changed by 22.83% million INR from the previous quarter.

S&P/TSX

36,626.61

+261.19

+0.72%

S&P/TSX 60

2,145.06

+13.55

+0.64%

US 30

53,307.20

+544.9

+1.03%

US 500

7,680.10

+38.4

+0.50%

S&P 500 VIX

15.12

-0.89

-5.56%

DAX

26,128.55

+145.51

+0.56%

Dollar Index

98.758

-0.055

-0.06%

Market Movers

Name	Last	Chg. %	Vol.
RBC	282.88	-0.16%	929.96K
Enbridge	69.48	-1.40%	3.68M
Agnico Eagle Mines	297.73	+1.92%	854.69K
Toronto Dominion Bank	161.50	+0.05%	1.18M
Sun Life Financial	108.90	+0.84%	1.55M
Bank of Montreal	240.24	+0.60%	688.31K
Wheaton Precious Metals	216.98	+4.74%	724.59K

Name	Last	Chg. %	Vol.
Lanebury Growth Capital	0.15	+200.00%	1.00K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
ePlay Digital	0.010	+100.00%	7.00K
James Bay Resources Ltd	0.020	+100.00%	1.00K
Pharmadrug	0.0100	+100.00%	2.00K
Beckett’s	0.010	+100.00%	5.00K
Iemr Resources	0.0100	+100.00%	4.00K

Name	Last	Chg. %	Vol.
Patriot Gold	0.01	-87.50%	1.00K
EnviroMetal Technologies	0.01	-50.00%	34.06K
Molecule Holdings	0.005	-50.00%	20.11K
Carson River Ventures	0.04	-50.00%	1.25K
Playground Ventures	0.010	-50.00%	1.00K
Psyched Wellness	0.01	-50.00%	8.28K
Albert Labs International	0.005	-50.00%	1.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Hut 8	109.620	-10.51%	751.16K
Celestica Inc.	409.54	-1.73%	141.71K
Toronto Dominion Bank	161.50	+0.05%	1.18M
Keel Infra	4.51	-3.63%	4.80M
HIVE Digital Tech	4.1300	-4.18%	4.06M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaa	33.75	+50.53%	50.80
A Aaaa	121.77	+48.93%	181.35
Aa Aaa	102.72	+46.24%	150.22
Aaaaaaa Aa A A	30.01	+45.02%	43.52
Aaaaaaaaaaa	8.85	+42.03%	12.57
Aa Aaaaaa	21.44	+40.30%	30.08
Aaaaaaaaaaaaaa	17.26	+39.66%	24.11

Name	Last	Upside	Fair Value
Aaaaaa	33.75	+50.53%	50.80
A Aaaa	121.77	+48.93%	181.35
Aa Aaa	102.72	+46.24%	150.22
Aaaaaaa Aa A A	30.01	+45.02%	43.52
Aaaaaaaaaaa	8.85	+42.03%	12.57
Aa Aaaaaa	21.44	+40.30%	30.08
Aaaaaaaaaaaaaa	17.26	+39.66%	24.11

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Marksans Pharma Ltd (MARK)

MARK Income Statement

FAQ

What was Marksans Pharma Ltd’s revenue at year end?

How much revenue did Marksans Pharma Ltd report in the most recent quarter?

What was Marksans Pharma Ltd’s net income for the year?

How much net income did Marksans Pharma Ltd post in the last quarter?

What was Marksans Pharma Ltd’s gross profit for the year?

How much gross profit did Marksans Pharma Ltd generate last quarter?

What was Marksans Pharma Ltd’s annual operating income?

What was Marksans Pharma Ltd’s operating income last quarter?

What was Marksans Pharma Ltd’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Marksans Pharma Ltd?

What is Marksans Pharma Ltd’s most recent gross profit margin?

What is Marksans Pharma Ltd’s most recent net income margin?

What is Marksans Pharma Ltd’s most recent EBIT margin?

How did Marksans Pharma Ltd’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Marksans Pharma Ltd?

Trending Stocks